These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22503307)

  • 21. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial.
    van Aart L; Eijkhout HW; Kamphuis JS; Dam M; Schattenkerk ME; Schouten TJ; Ploeger B; Strengers PF
    Thromb Res; 2006; 118(3):313-20. PubMed ID: 16182346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
    Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombin complex concentrate (PCC, Octaplex) in patients requiring immediate reversal of vitamin K antagonist anticoagulation.
    Song MM; Warne CP; Crowther MA
    Thromb Res; 2012 Apr; 129(4):526-9. PubMed ID: 22304928
    [No Abstract]   [Full Text] [Related]  

  • 25. Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal.
    Zemrak W; Manuel F; Smith KE; Rolfe S; Hayes T; Trowbridge RL; Carlone B; Seder D
    J Thromb Thrombolysis; 2019 Feb; 47(2):263-271. PubMed ID: 30443817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of Octaplex dosing accuracy: an in vitro analysis.
    Patriquin CJ; Chin-Yee IH; Kovacs MJ; Lazo-Langner A; Keeney M; Hsia CC
    Thromb Haemost; 2012 Feb; 107(2):248-52. PubMed ID: 22186847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
    Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
    J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience.
    Mačiukaitienė J; Bilskienė D; Tamašauskas A; Bunevičius A
    Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344253
    [No Abstract]   [Full Text] [Related]  

  • 29. Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage.
    Rowe AS; Mahbubani PS; Bucklin MH; Clark CT; Hamilton LA
    Pharmacotherapy; 2016 Nov; 36(11):1132-1137. PubMed ID: 27726162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Stoecker Z; Van Amber B; Woster C; Isenberger K; Peterson M; Rupp P; Chrenka E; Dries D
    Am J Emerg Med; 2021 Oct; 48():282-287. PubMed ID: 34022636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of vitamin K antagonists prior to urgent surgery.
    Grobler C; Callum J; McCluskey SA
    Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal.
    Gilbert BW; Morton L; Huffman JB; Roemer K; Potter A; Cassidy CD; Vasquez DG
    Am J Emerg Med; 2020 Apr; 38(4):806-809. PubMed ID: 31864879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
    Wiedermann CJ; Stockner I
    Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy.
    Khorsand N; Veeger NJ; Muller M; Overdiek JW; Huisman W; van Hest RM; Meijer K
    Transfus Med; 2011 Apr; 21(2):116-23. PubMed ID: 21073580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter, Retrospective, Propensity-Matched Pilot Study.
    Jones GM; Erdman MJ; Smetana KS; Mohrien KM; Vandigo JE; Elijovich L
    J Thromb Thrombolysis; 2016 Jul; 42(1):19-26. PubMed ID: 26721625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate.
    Peksa GD; Mokszycki RK; Rech MA; Maynard B; Panos NG; Sweis RT; DeMott JM
    Thromb Haemost; 2020 Feb; 120(2):207-215. PubMed ID: 31837652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
    Pinner NA; Hurdle AC; Oliphant C; Reaves A; Lobo B; Sills A
    World Neurosurg; 2010 Dec; 74(6):631-5. PubMed ID: 21492631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
    Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
    Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose.
    Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K
    Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.